0001181431-11-043431.txt : 20110802 0001181431-11-043431.hdr.sgml : 20110802 20110802161622 ACCESSION NUMBER: 0001181431-11-043431 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110731 FILED AS OF DATE: 20110802 DATE AS OF CHANGE: 20110802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bahrt Kenneth CENTRAL INDEX KEY: 0001527197 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 111003769 MAIL ADDRESS: STREET 1: ONE TOWER CENTER BLVD CITY: EAST BRUNSWICK STATE: NJ ZIP: 08619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd318798.xml FORM 3 X0204 3 2011-07-31 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001527197 Bahrt Kenneth ONE TOWER CENTER BLVD. 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, Chief Medical Officer Common Stock, $.01 par value per share 50000 D Option to Purchase Common Stock, $01 par value 7.00 2011-07-31 2021-07-31 Common Stock, $.01 par value per share 150000 D The right to receive these shares is pursuant to a restricted stock grant that vests as follows: 12,500 on July 31, 2012, and 3,125 shares at the end of each successive three-month period until July 31, 2015, provided that the grantee remains employed by the Company on these dates. These options will become exercisable as follows: 37,500 on July 31, 2012, and 9,375 shares at the end of each successive three-month period until July 31, 2015, provided the optionee remains employed by the Company on these dates. /s/ Irina Azer for Kenneth Bahrt 2011-08-02 EX-24.1 2 rrd285852_322819.htm POWER OF ATTORNEY rrd285852_322819.html 
 		                  	Savient Pharmaceuticals,
Inc.


POWER OF ATTORNEY

       Know all by these presents, that the undersigned hereby constitutes and appoints each of
Philip K. Yachmetz, Esq. and Irina Azer Ishak, signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1)        execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Savient Pharmaceuticals, Inc. (the
"Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;

(2)        do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3,
4, or 5, complete and execute any amendment or amendments thereto, and
timely file such form with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and

(3)        take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in
the best interest of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and authority to
do and perform any and every act and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted.  The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.
         This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 31st day of July, 2011.



		Signature
Kenneth Bahrt
		Print Name




Power of Attorney
Page 2